Key updates from SABCS 2024 in early breast cancer include the COMET study on DCIS recurrence, INSEMA trial on SLNB omission, and OlympiA updates on adjuvant olaparib, shared by Dr Harold Burstein.
When Dani Yuengling felt a lump in her right breast last summer, she tried to ignore it. She was 35, the same age her mother had been when she received a breast cancer diagnosis in 1997. The disease ...